Showing results (61-70 of 299) with videos related to
Sort By:
Pageof 30
Cardiovascular and Interventional Radiology|January 26, 2012
Sharp recanalization for chronic left iliac vein occlusionNobutake Ito, Peter Isfort, Tobias Penzkofer, et al.Cardiovascular and Interventional Radiology|May 5, 2010
Pull-through technique for recanalization of occluded portosystemic shunts (TIPS): technical note and review of the literatureToshihiro Tanaka, Rolf W Günther, Peter Isfort, et al.Carcinogenesis|June 1, 1994
Growth factor responsiveness and alterations in growth factor homeostasis in Syrian hamster embryo cells during in vitro transformationR J Isfort, D B Cody, G A Kerckaert, et al.Journal of Virology|February 1, 1986
Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoproteinR J Isfort, R A Stringer, H J Kung, et al.Pflege|May 31, 2016
Internal consistency and construct validity of the Quality of Life in Alzheimer's Disease (QoL-AD) proxy – a secondary data analysisJonas Hylla, Christian G G Schwab, Michael Isfort, et al.Fortschritte Der Medizin. Originalien|March 5, 2003
[Evidence-based guidelines as tools for medical knowledge transfer. The work mode of the Medical Knowledge Network evidence.de]H C Vollmar, N Koneczny, B Floer, et al.Family Practice|March 17, 2004
Learning with computerized guidelines in general practice?: A randomized controlled trialM Butzlaff, H C Vollmar, B Floer, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 23, 2004
Corticotropin-releasing factor 2 receptor localization in skeletal muscleSteven Samuelsson, Jana S Lange, Richard T Hinkle, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
Bosutinib: a novel second-generation tyrosine kinase inhibitorSusanne Isfort, Gunhild Keller-v Amsberg, Philippe Schafhausen, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Bosutinib: A Potent Second-Generation Tyrosine Kinase InhibitorSusanne Isfort, Martina Crysandt, Deniz Gezer, et al.Pageof 30